Skip to main content

Advertisement

Log in

Incidence and risk factor for infection of totally implantable venous access port

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.

Methods

From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.

Results

A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (p = 0.03) and inpatient setting (p < 0.001) was the risk factor of early infection, and TIVAP combined with other surgeries (p = 0.007), hematological cancer (p = 0.03), and inpatient setting (p < 0.001) was the risk factor of late infection.

Conclusion

Inpatient TIVAP implantation and TIVAP implantation combined with other surgeries are associated with high rates of TIVAP-related early and late infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author, Tung-Cheng Chang, upon reasonable request.

References

  1. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712

    CAS  PubMed  Google Scholar 

  2. Zerati AE, Figueredo TR, de Moraes RD, da Cruz AM, da Motta-Leal Filho JM, Freire MP et al (2016) Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients. J Vasc Surg Venous Lymphat Disord 4:200–205

    Article  Google Scholar 

  3. Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S et al (2012) Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine 9:309–318

    Article  Google Scholar 

  4. Vidal M, Genillon JP, Forestier E, Trouiller S, Pereira B, Mrozek N et al (2016) Outcome of totally implantable venous-access port-related infections. Med Mal Infect 46:32–38

    Article  CAS  Google Scholar 

  5. Tang L, Kim CY, Martin JG, Pabon-Ramos WM, Sag AA, Suhocki PV et al (2020) Length of stay predicts risk of early infection for hospitalized patients undergoing central venous port placement. J Vasc Interv Radiol 31:454–461

    Article  Google Scholar 

  6. Voog E, Campion L, du Rusquec P, Bourgeois H, Domont J, Denis F et al (2018) Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer 26:81–89

    Article  Google Scholar 

  7. Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y (2007) Risk factors for early catheter-related infections in cancer patients. Cancer 110:1586–1592

    Article  Google Scholar 

  8. Shim J, Seo TS, Song MG, Cha IH, Kim JS, Choi CW et al (2014) Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol 15:494–500

    Article  Google Scholar 

  9. Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R et al (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care 19:676–681

    Article  CAS  Google Scholar 

  10. Pandey N, Chittams JL, Trerotola SO (2013) Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement. J Vasc Interv Radiol 24:849–854

    Article  Google Scholar 

  11. Erinjeri JP, Fong AJ, Kemeny NE, Brown KT, Getrajdman GI, Solomon SB (2011) Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 117:1296–1301

    Article  CAS  Google Scholar 

  12. Bamba R, Lorenz JM, Lale AJ, Funaki BS, Zangan SM (2014) Clinical predictors of port infections within the first 30 days of placement. J Vasc Interv Radiol 25:419–423

    Article  Google Scholar 

  13. Zhang S, Kobayashi K, Faridnia M, Skummer P, Zhang D, Karmel MI (2018) Clinical predictors of port infections in adult patients with hematologic malignancies. J Vasc Interv Radiol 29:1148–1155

    Article  Google Scholar 

  14. Stone AM, Tucci VJ, Isenberg HD, Wise L (1976) Wound infection: a prospective study of 7519 operations. Am Surg 42:849–852

    CAS  PubMed  Google Scholar 

  15. Drake CT, Goldman E, Nichols RL, Piatriszka K, Nyhus LM (1977) Environmental air and airborne infections. Ann Surg 185:219–223

    Article  CAS  Google Scholar 

  16. Hsieh CC, Weng HH, Huang WS, Wang WK, Kao CL, Lu MS et al (2009) Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 15:4709–4714

    Article  Google Scholar 

  17. Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P et al (2009) Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port. Med Mal Infect 39:252–258

    Article  CAS  Google Scholar 

  18. Doyon L, Moreno-Koehler A, Ricciardi R, Nepomnayshy D (2016) Resident participation in laparoscopic Roux-en-Y gastric bypass: a comparison of outcomes from the ACS-NSQIP database. Surg Endosc 30:3216–3224

    Article  Google Scholar 

  19. Relles DM, Burkhart RA, Pucci MJ, Sendecki J, Tholey R, Drueding R et al (2014) Does resident experience affect outcomes in complex abdominal surgery? Pancreaticoduodenectomy as an example. J Gastrointest Surg 18:279–285

    Article  Google Scholar 

  20. Schreckenbach T, Münch I, El Youzouri H, Bechstein WO, Habbe N (2019) The safety level of total central venous access port implantation performed by residents. J Surg Educ 76:182–192

    Article  Google Scholar 

  21. Wang T, Wang H, Yang DL, Jiang LQ, Zhang LJ, Ding WY (2017) Factors predicting surgical site infection after posterior lumbar surgery: a multicenter retrospective study. Medicine (Baltimore) 96:e6042

    Article  Google Scholar 

  22. Karim H, Chafik K, Karim K, Moez H, Makki AM, Adnen el-H et al (2000) Risk factors for surgical wound infection in digestive surgery. Retrospective study of 3,000 surgical wounds. Tunis Med 78:634–640

    CAS  PubMed  Google Scholar 

  23. Nocito A, Wildi S, Rufibach K, Clavien PA, Weber M (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. Br J Surg 96:1129–1134

    Article  CAS  Google Scholar 

  24. Hüttner FJ, Bruckner T, Hackbusch M, Weitz J, Bork U, Kotschenreuther P et al (2020) Primary open versus closed implantation strategy for totally implantable venous access ports: the multicentre randomized controlled PORTAS-3 Trial (DRKS 00004900). Ann Surg. https://doi.org/10.1097/SLA.0000000000003705

    Article  PubMed  Google Scholar 

  25. Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B et al (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–159

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conception and design: Min-Hsuan Yen and Tung-Cheng Chang. Acquisition of data: Min-Hsuan Yen and Tung-Cheng Chang. Analysis and interpretation data: Min-Hsuan Yen, Kee-Thai Kiu and Tung-Cheng Chang. Writing, review, and revision of the manuscript: Tung-Cheng Chang.

Corresponding author

Correspondence to Tung-Cheng Chang.

Ethics declarations

Ethics approval

This study was approved by the ethics committee of the Taipei Medical University (approval number: N201801072) and performed according to the declaration of Helsinki of 1964 and its later amendments or comparable ethical standards.

Informed consent

Informed consent was not applicable due to the retrospective nature of this study.

Conflict of interest

The authors declare no competing of interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chang, TC., Yen, MH. & Kiu, KT. Incidence and risk factor for infection of totally implantable venous access port. Langenbecks Arch Surg 407, 343–351 (2022). https://doi.org/10.1007/s00423-021-02328-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02328-0

Keywords

Navigation